Atlas Trials

Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Clinical trial NCT00838656 · UNKNOWN

Trial details

NCT number
NCT00838656
Sponsor
Warwick Medical School
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Start date
2007-10-01
Primary completion
2009-06-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.